Summary of the Conference Call for Denghai Seed Industry Industry Overview - In 2025, the corn seed production area is expected to decrease to 3.6-3.8 million acres, primarily due to high inventory levels and increased demand for variety updates, with a market preference for high-density and disease-resistant varieties, maintaining historical high levels overall [2][7] - The overall industry destocking cycle is uncertain, potentially taking two to three years to recover from the low point, influenced by market trends and policy signals [2][8] Company Insights - Key transgenic varieties include 1,605D, 710D, 533D, and 685D, with 1,605D sales exceeding 1 million acres last year and expected to expand this year [2][9] - The retail price for transgenic varieties is approximately 65-70 yuan per acre, with pricing determined through negotiations with partners like Dabeinong and the Chinese Academy of Agricultural Sciences [2][10][11] - The company is focusing on the demand for high-density and disease-resistant varieties, launching new products like MY73 and developing new high-density varieties such as 997 for production trials [2][15] Financial Performance - The overall cost of corn seeds is trending downwards, with a decrease in per-acre production costs by several hundred yuan, although complete data will be available by the end of the year [5] - The company has seen a reduction in contract liabilities from January to September 2025, attributed to decreased prepayments due to sales issues [20] Market Dynamics - The sales progress for the new season is not fully disclosed yet, with significant sales expected to begin in November, which is typically the peak sales period [13] - The price trend for 2025 shows a decline for conventional corn varieties due to high inventory, while transgenic corn prices remain stable [14] Research and Development - The company has partnered with the Shandong Academy of Agricultural Sciences to develop biosafety certificate transformation bodies, ranking first in the industry, and plans to compete in trait segments [3][18] - There are plans to commercialize newly developed varieties, as self-use alone cannot meet demand [19] - The company has not yet ventured into gene editing but may consider it in the future, supported by local agricultural institutions [21] Future Outlook - The company is optimistic about the future of transgenic varieties like 605D, 685D, and 710D, which will require 1-2 years of trial planting before expanding sales [17] - The overall industry is expected to face changes in supply-demand dynamics, but the potential for conventional varieties with excellent resistance traits remains promising [22] Additional Information - Investors are encouraged to visit the company for further research and discussions [23]